Last Updated on May 13, 2020 by HepFree NYC
Tags: Hepatitis C HepCX NewsExamining Hepatitis C Virus Treatment Access
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
-
Win $150! Participate in our Logo Design Competition for Hep Awareness Events
News
Your logo will be printed on banners, flags, and flyers for Hepatitis Awareness events, including the Hep Free NYC Awareness Event on the steps of City Hall, May 10, 11 AM - 12 PM.
-
Webinar | Eliminating Hep B & C in the US (Hep B United)
News
Please join Hep B United and the National Viral Hepatitis Roundtable on Monday, April 10, 2017 at 2:00 pm EDT
-
Comment! Hep C Screening Recommendations (USPSTF)
News
The USPSTF gives a “B” rating for testing hepatitis C among injection drug users and others at high risk, a major improvement over previous guidelines However, the Task Force failed to match the Centers for Disease Control and Prevention’s lifesaving recommendation of testi...
-
Viekira Pak now preferred under NYS Medicaid Fee For Service (FFS)
News, HepCX News, Medicaid, Pharmaceutical
On Feb 26th, 2015, the NYS Drug Utilization Review Board (DURB) voted unanimously to move Viekira Pak to preferred status for NYS Medicaid Fee-for-service members, and to remove restrictions based on disease prognosis and severity from the current clinical criteria for Viekira Pa...
-
USPSTF Recommends Hep B Screening in High Risk Individuals
News
The updated recommendation comes after growing evidence on the effectiveness of antiviral treatments, and is in line with recommendations from the CDC and the American Association for the Study of Liver Diseases. The USPSTF has a separate Grade A Recommendation on screening fo...
-
National Strategy for Elimination of Hep, Phase 2 Report Released
News
The report identifies new opportunities for preventing transmission and recommends steps to ensure people are tested, treated, and/or cured of hepatitis.
-
NYC Health Department Announces Strategic Plan to Combat Hepatitis C
News
The NYC Health Department today released the City's first-ever plan for reducing illness and death from the hepatitis C virus (HCV), a disease that now accounts for more annual deaths nationwide than HIV/AIDS
-
FDA Approves Zepatier for Treatment of Hep C
News, FDA, Hepatitis C, HepCX News, Pharmaceutical
The U.S. Food and Drug Administration has approved Zepatier with or without ribavirin for the treatment of chronic Hepatitis C genotypes 1 and 4 infections in adult patients.
Upcoming Events
CME | Epidemiology of Hep C (HepCure/CEI)
Hep Telehealth Workgroup
NVHR Grassroots Advocacy Monthly Call
News & Recent Posts
- Job | Hep C Harm Reduction Peer Worker (Housing Works) January 13, 2021
- NY City Council Discretionary Funding Application | Due 2/19/2021 January 13, 2021
- Research Committee Meeting Highlights | 12-16-2020 January 8, 2021
- NYC Council Viral Hepatitis Initiative January 1, 2021
- Updated Hep B Screening Recommendation (U.S. Preventive Services Task Force) December 28, 2020
- Job | Viral Hepatitis Program Medical Director @ NYC Health Dept December 21, 2020